☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Biocon Biologics
Biocon Biologics’ Yesafili (biosimilar, aflibercept) Receives EC’s Approval for Ophthalmic Conditions
September 22, 2023
Biocon Biologics Receives EMA’s CHMP Positive Opinion of Yesafili (biosimilar, aflibercept)
July 24, 2023
Biocon Biologics and its Partner Viatris Receive the Complete Response Letter from the US FDA for Bevacizumab Biosimilar
January 12, 2023
PharmaShots Weekly Snapshots (April 26 - 30, 2021)
April 30, 2021
PharmaShots Weekly Snapshots (Mar 01 - 05, 2021)
March 5, 2021
PharmaShots Weekly Snapshot (February 01-05, 2021)
February 5, 2021
Load more...
Back to Home
Modal title
×
Modal body text goes here.